| Jessica Elizabeth Johnson, MD | |
|
1 Medical Center Dr, Morgantown, WV 26506-1200 | |
| (559) 882-2738 | |
| Not Available |
| Full Name | Jessica Elizabeth Johnson |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 10 Years |
| Location | 1 Medical Center Dr, Morgantown, West Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124438890 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | 27084 (West Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| West Virginia University Hospitals | Morgantown, WV | Hospital |
| Uniontown Hospital | Uniontown, PA | Hospital |
| Potomac Valley Hospital | Keyser, WV | Hospital |
| St Joseph's Hospital | Buckhannon, WV | Hospital |
| Barnesville Hospital Association, Inc | Barnesville, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| West Virginia University Medical Corporation | 1052224565 | 1613 |
News Archive
Disease management programs that help guide the care of patients with chronic health problems appear to improve the quality of health care, but there is little evidence that such efforts actually save money, according to a study issued by the RAND Corporation.
A pharmacological interaction occurs when the effects of a one drug are modified by the presence of another. The consequences can be harmful if the interaction causes an increase in the toxicity of the drug or if it diminishes its effect, possibly even causing the patient's death, in the worst case scenario. At present, there are databases for checking possible interactions between drugs administered to patients, but the main problem is that many of the databases are not updated for three years.
Philosophers, historians, economists, social scientists and creative arts practitioners will gather next week at the University of Hertfordshire to discuss what happiness means and how a greater depth of the state can be achieved.
Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced that detailed data from its open-label Phase 2 clinical study of PRX302 in patients with moderate to severe benign prostatic hyperplasia (BPH) will be presented at the 30th World Congress of the Société Internationale d'Urologie Conference.
A team of Toronto-based researchers may be one step closer to a 'recipe' for large-scale production of stem cells for use in research and therapy.
› Verified 3 days ago
| Entity Name | West Virginia University Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275504508 PECOS PAC ID: 1052224565 Enrollment ID: O20031111000207 |
News Archive
Disease management programs that help guide the care of patients with chronic health problems appear to improve the quality of health care, but there is little evidence that such efforts actually save money, according to a study issued by the RAND Corporation.
A pharmacological interaction occurs when the effects of a one drug are modified by the presence of another. The consequences can be harmful if the interaction causes an increase in the toxicity of the drug or if it diminishes its effect, possibly even causing the patient's death, in the worst case scenario. At present, there are databases for checking possible interactions between drugs administered to patients, but the main problem is that many of the databases are not updated for three years.
Philosophers, historians, economists, social scientists and creative arts practitioners will gather next week at the University of Hertfordshire to discuss what happiness means and how a greater depth of the state can be achieved.
Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced that detailed data from its open-label Phase 2 clinical study of PRX302 in patients with moderate to severe benign prostatic hyperplasia (BPH) will be presented at the 30th World Congress of the Société Internationale d'Urologie Conference.
A team of Toronto-based researchers may be one step closer to a 'recipe' for large-scale production of stem cells for use in research and therapy.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jessica Elizabeth Johnson, MD 1 Medical Center Dr, Morgantown, WV 26506-1200 Ph: (855) 988-2273 | Jessica Elizabeth Johnson, MD 1 Medical Center Dr, Morgantown, WV 26506-1200 Ph: (559) 882-2738 |
News Archive
Disease management programs that help guide the care of patients with chronic health problems appear to improve the quality of health care, but there is little evidence that such efforts actually save money, according to a study issued by the RAND Corporation.
A pharmacological interaction occurs when the effects of a one drug are modified by the presence of another. The consequences can be harmful if the interaction causes an increase in the toxicity of the drug or if it diminishes its effect, possibly even causing the patient's death, in the worst case scenario. At present, there are databases for checking possible interactions between drugs administered to patients, but the main problem is that many of the databases are not updated for three years.
Philosophers, historians, economists, social scientists and creative arts practitioners will gather next week at the University of Hertfordshire to discuss what happiness means and how a greater depth of the state can be achieved.
Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced that detailed data from its open-label Phase 2 clinical study of PRX302 in patients with moderate to severe benign prostatic hyperplasia (BPH) will be presented at the 30th World Congress of the Société Internationale d'Urologie Conference.
A team of Toronto-based researchers may be one step closer to a 'recipe' for large-scale production of stem cells for use in research and therapy.
› Verified 3 days ago
Rohma Shamsi, M.D. Infectious Disease Medicare: Medicare Enrolled Practice Location: 1 Medical Center Drive, Morgantown, WV 26506 Phone: 304-293-4125 | |
Islam Younes, Infectious Disease Medicare: Medicare Enrolled Practice Location: 1 Medical Center Dr, Morgantown, WV 26506 Phone: 855-988-2273 | |
Dr. David Weissman, M. D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 1 Stadium Drive, Morgantown, WV 26506 Phone: 304-598-4800 Fax: 304-293-6963 | |
Dr. Madhavi Kadiyala, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Morgantown, WV 26506 Phone: 304-598-4000 | |
Dr. Swapna Gayam, M.D Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Drive, Morgantown, WV 26506 Phone: 304-293-4123 Fax: 304-293-2135 | |
Monika Maximilliane Holbein, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Morgantown, WV 26506 Phone: 304-594-4000 | |
Nour Daboul, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Morgantown, WV 26506 Phone: 855-988-2273 |